• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

爱丁堡乳腺癌筛查试验:七年死亡率

Edinburgh trial of screening for breast cancer: mortality at seven years.

作者信息

Roberts M M, Alexander F E, Anderson T J, Chetty U, Donnan P T, Forrest P, Hepburn W, Huggins A, Kirkpatrick A E, Lamb J

机构信息

Edinburgh Breast Screening Centre, University of Edinburgh, UK.

出版信息

Lancet. 1990 Feb 3;335(8684):241-6. doi: 10.1016/0140-6736(90)90066-e.

DOI:10.1016/0140-6736(90)90066-e
PMID:1967717
Abstract

Between 1979 and 1981, 45,130 women in Edinburgh aged 45-64 were entered into a randomised trial of breast cancer screening by mammography and clinical examination. The initial attendance rate was 61% but this varied according to age and socioeconomic status and decreased over succeeding years. The cancer detection rate was 6.2 per 1000 women attending at the first visit; the rate fell to around 3 per 1000 in the years when mammography was routinely repeated and to around 1 per 1000 at the intervening visits with clinical examination alone as the screening method. After 7 years of follow-up the mortality reduction achieved was 17% (relative risk = 0.83, 95% CI 0.58-1.18), which was not statistically significant, even when corrected for socioeconomic status. In women aged 50 years and over a mortality reduction of 20% was achieved.

摘要

1979年至1981年间,爱丁堡45至64岁的45130名女性参与了一项通过乳房X光造影和临床检查进行乳腺癌筛查的随机试验。初始参与率为61%,但因年龄和社会经济地位而异,并在随后几年有所下降。首次就诊时,每1000名女性的癌症检出率为6.2;在常规重复进行乳房X光造影的年份,该比率降至每1000人约3例,而在仅以临床检查作为筛查方法的中间就诊时,该比率降至每1000人约1例。经过7年的随访,死亡率降低了17%(相对风险=0.83,95%置信区间0.58-1.18),即使在对社会经济地位进行校正后,这一结果也无统计学意义。在50岁及以上的女性中,死亡率降低了20%。

相似文献

1
Edinburgh trial of screening for breast cancer: mortality at seven years.爱丁堡乳腺癌筛查试验:七年死亡率
Lancet. 1990 Feb 3;335(8684):241-6. doi: 10.1016/0140-6736(90)90066-e.
2
Canadian National Breast Screening Study: 2. Breast cancer detection and death rates among women aged 50 to 59 years.加拿大全国乳腺筛查研究:2. 50至59岁女性的乳腺癌检出率和死亡率。
CMAJ. 1992 Nov 15;147(10):1477-88.
3
Canadian National Breast Screening Study: 1. Breast cancer detection and death rates among women aged 40 to 49 years.加拿大全国乳腺筛查研究:1. 40至49岁女性的乳腺癌检出率和死亡率。
CMAJ. 1992 Nov 15;147(10):1459-76.
4
14 years of follow-up from the Edinburgh randomised trial of breast-cancer screening.来自爱丁堡乳腺癌筛查随机试验的14年随访结果。
Lancet. 1999 Jun 5;353(9168):1903-8. doi: 10.1016/s0140-6736(98)07413-3.
5
16-year mortality from breast cancer in the UK Trial of Early Detection of Breast Cancer.英国乳腺癌早期检测试验中的乳腺癌16年死亡率。
Lancet. 1999 Jun 5;353(9168):1909-14.
6
Mammographic screening of women aged 40 to 49 years. Is it justified?对40至49岁女性进行乳腺钼靶筛查。这合理吗?
Obstet Gynecol Clin North Am. 1994 Dec;21(4):587-606.
7
Current management of primary breast cancer. Part I: Screening, diagnosis, staging and local treatment of stage I and II disease.原发性乳腺癌的当前管理。第一部分:I期和II期疾病的筛查、诊断、分期及局部治疗。
Mo Med. 1990 Sep;87(9):684-90.
8
Canadian National Breast Screening Study-2: 13-year results of a randomized trial in women aged 50-59 years.加拿大国家乳腺筛查研究-2:针对50至59岁女性的一项随机试验的13年结果。
J Natl Cancer Inst. 2000 Sep 20;92(18):1490-9. doi: 10.1093/jnci/92.18.1490.
9
Natural history of breast cancers detected in the Swedish mammography screening programme: a cohort study.在瑞典乳腺 X 光筛查计划中检出的乳腺癌的自然史:一项队列研究。
Lancet Oncol. 2011 Nov;12(12):1118-24. doi: 10.1016/S1470-2045(11)70250-9. Epub 2011 Oct 11.
10
The Edinburgh Randomized Trial of Breast Cancer Screening.
J Natl Cancer Inst Monogr. 1997(22):31-5. doi: 10.1093/jncimono/1997.22.31.

引用本文的文献

1
Strong association between reduction of late-stage cancers and reduction of cancer-specific mortality in meta-regression of randomized screening trials across multiple cancer types.在多个癌症类型的随机筛查试验的荟萃回归中,晚期癌症的减少与癌症特异性死亡率的降低之间存在很强的关联。
J Med Screen. 2024 Dec;31(4):211-222. doi: 10.1177/09691413241256744. Epub 2024 May 26.
2
Breast cancer outcomes based on method of detection in community-based breast cancer registry.基于社区乳腺癌登记处的检测方法的乳腺癌结局。
Breast Cancer Res Treat. 2024 Jan;203(2):215-224. doi: 10.1007/s10549-023-07092-x. Epub 2023 Oct 25.
3
The Impact of Organised Screening Programs on Breast Cancer Stage at Diagnosis for Canadian Women Aged 40-49 and 50-59.
加拿大 40-49 岁和 50-59 岁女性乳腺癌诊断时的分期:有组织的筛查项目的影响。
Curr Oncol. 2022 Aug 9;29(8):5627-5643. doi: 10.3390/curroncol29080444.
4
The age-specific differences in histopathological tumor characteristics and TNM classification of breast carcinomas in Quality assured mamma diagnostic (QuaMaDi) program in the state of Schleswig-Holstein in Germany.德国石勒苏益格-荷尔斯泰因州质量保证乳房诊断(QuaMaDi)计划中乳腺癌的组织病理学肿瘤特征和 TNM 分类的年龄特异性差异。
J Cancer Res Clin Oncol. 2022 Feb;148(2):387-400. doi: 10.1007/s00432-021-03841-x. Epub 2021 Oct 27.
5
The impact of the Polish mass breast cancer screening program on prognosis in the Pomeranian Province.波兰大规模乳腺癌筛查项目对波美拉尼亚省预后的影响。
Arch Med Sci. 2017 Mar 1;13(2):441-447. doi: 10.5114/aoms.2016.60387. Epub 2016 Jun 6.
6
Clarifying the debate on population-based screening for breast cancer with mammography: A systematic review of randomized controlled trials on mammography with Bayesian meta-analysis and causal model.用乳腺钼靶进行基于人群的乳腺癌筛查辩论的澄清:一项对乳腺钼靶随机对照试验的系统评价,采用贝叶斯荟萃分析和因果模型
Medicine (Baltimore). 2017 Jan;96(3):e5684. doi: 10.1097/MD.0000000000005684.
7
A five year audit of mammography in a tertiary hospital, North Central Nigeria.尼日利亚中北部一家三级医院的五年乳腺钼靶检查审计
Niger Med J. 2015 May-Jun;56(3):213-7. doi: 10.4103/0300-1652.160401.
8
Limitations of mammography in the diagnosis of breast diseases compared with ultrasonography: a single-center retrospective analysis of 274 cases.与超声检查相比,乳腺钼靶摄影在乳腺疾病诊断中的局限性:一项对274例病例的单中心回顾性分析
Eur J Med Res. 2015 Apr 21;20(1):49. doi: 10.1186/s40001-015-0140-6.
9
Were our estimates of overdiagnosis with mammography screening in the United States "based on faulty science"?我们对美国乳房 X 光筛查过度诊断的估计“基于错误的科学”吗?
Oncologist. 2014 Feb;19(2):113-26. doi: 10.1634/theoncologist.2013-0383.
10
Rational and irrational issues in breast cancer screening.乳腺癌筛查中的理性与非理性问题。
Cancers (Basel). 2011 Jan 11;3(1):252-66. doi: 10.3390/cancers3010252.